Stockscreener 앱 받기
12.21
0.73%
-0.09
Ocular Therapeutix Inc 주식(OCUL)의 최신 뉴스
Ocular Therapeutix Inc. Stock Poised for Technical ComebackLow Capital High Return Stock Plans Reviewed - beatles.ru
ETF Channel: ITOT Expected to Reach $154 - AInvest
Analysts Have Made A Financial Statement On Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) Second-Quarter Report - Yahoo Finance
Optimistic Buy Rating for Ocular Therapeutix Driven by Promising Clinical Trials and Strategic Decisions - TipRanks
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2025 Earnings Call Transcript - MSN
Ocular Therapeutix stock hits 52-week high at 12.38 USD - Investing.com
Ocular Therapeutix: Q2 Earnings Snapshot - Huron Daily Tribune
Ocular Therapeutix Inc (OCUL) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial Strength - GuruFocus
Ocular Therapeutix Inc (OCUL) Q2 2025 Earnings Call Highlights: Strategic Advances and ... By GuruFocus - Investing.com Canada
Ocular Therapeutix 2025 Q2 Earnings Deepening Losses Amid Strategic Momentum - AInvest
Ocular Therapeutix Reports Second Quarter 2025 Financial Results - VisionMonday.com
Ocular Therapeutix Reports Q2 2025 Financial Results - TipRanks
Decoding Ocular Therapeutix Inc (OCUL): A Strategic SWOT Insight - GuruFocus
Ocular Therapeutix Q2 2025 Sales Down 18%, R&D Expenses Surge 76.9% Amid Reimbursement Pressure - AInvest
OCUL Sales Drop 18% - The Motley Fool
Ocular Therapeutix Earnings Call: Positive Outlook Amid Trial Progress - TipRanks
Ocular Therapeutix Q2 2025: Unpacking Key Contradictions in SOL-R Trial Criteria and FDA Relations - AInvest
Ocular Therapeutix stock maintains Buy rating at TD Cowen ahead of Phase III data - Investing.com Canada
Ocular Therapeutix Q2 2025 Earnings Call Transcript - MarketBeat
Clear Street reiterates Buy rating on Ocular Therapeutix stock at $18 - Investing.com Canada
Raymond James reiterates Strong Buy on Ocular Therapeutix stock with $19 target - Investing.com Canada
Earnings call transcript: Ocular Therapeutix misses Q2 2025 earnings, stock drops - Investing.com
Ocular Therapeutix Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Quant Strategy Flags Ocular Therapeutix Inc. for EntryLow Risk Swing Trade Opportunities Identified - beatles.ru
Ocular Therapeutix tumbles as Q2 results miss estimates - Investing.com
Ocular Therapeutix: Can AXPAXLI's Pipeline Offset Financial Headwinds? - AInvest
Ocular Therapeutix Q2 Loss Widens, Revenue Falls; Shares Down Pre-Bell - MarketScreener
Ocular Therapeutix (OCUL) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings Flash (OCUL) Ocular Therapeutix Posts Q2 Net Loss $0.39 a Share, vs. FactSet Est of $0.35 Loss - MarketScreener
Ocular Therapeutix Inc earnings missed by $0.04, revenue fell short of estimates - Investing.com
Ocular Therapeutix Reports Second Quarter 2025 Financial Results and Business Highlights - TradingView
Earnings Flash (OCUL) Ocular Therapeutix, Inc. Reports Q2 Revenue $13.5M, vs. FactSet Est of $13.6M - MarketScreener
Ocular Therapeutix™ Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
OCULAR THERAPEUTIX, INC SEC 10-Q Report - TradingView
Ocular Therapeutix raises $97mln, expects cash runway into 2028. - AInvest
What's Next: Ocular Therapeutix's Earnings Preview - 富途牛牛
Ocular Therapeutix stock maintains Strong Buy rating at Raymond James By Investing.com - Investing.com Canada
Ocular Therapeutix Inc (OCUL) Q2 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
What analysts say about Ocular Therapeutix Inc. stockBuild wealth with high-performing stocks - Jammu Links News
Is Ocular Therapeutix Inc. a growth stock or a value stockHigh-yield investments - Jammu Links News
When is Ocular Therapeutix Inc. stock expected to show significant growthAchieve impressive returns with smart timing - Jammu Links News
What are the latest earnings results for Ocular Therapeutix Inc.Capitalize on market shifts with expert advice - Jammu Links News
How does Ocular Therapeutix Inc. compare to its industry peersBreakout stock performance - Jammu Links News
How does Ocular Therapeutix Inc. generate profit in a changing economyInvest confidently with data-backed picks - Jammu Links News
Is it the right time to buy Ocular Therapeutix Inc. stockTriple-digit growth rates - Jammu Links News
Should I hold or sell Ocular Therapeutix Inc. stock in 2025Capitalize on market trends with expert guidance - Jammu Links News
How volatile is Ocular Therapeutix Inc. stock compared to the marketBuild a diversified portfolio for steady profits - Jammu Links News
What are Ocular Therapeutix Inc. company’s key revenue driversGet daily updates on top-performing stocks - Jammu Links News
Is Ocular Therapeutix Inc. stock overvalued or undervaluedBuild wealth steadily with smart trading - Jammu Links News
What is Ocular Therapeutix Inc. company’s growth strategyAchieve rapid portfolio appreciation - Jammu Links News
How strong is Ocular Therapeutix Inc. company’s balance sheetExtraordinary performance - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):